logo
Suffolk battery farms 'emerging risk' for fire crews, says chief

Suffolk battery farms 'emerging risk' for fire crews, says chief

BBC News27-05-2025

A fire service wants more power to enforce safety measures for battery energy storage systems (BESS).BESS stockpile green energy by using thousands of lithium-ion batteries in storage containers, but there are concerns about fire safety.Henry Griffin, Suffolk's deputy chief fire officer, described the sites as an "emerging risk" and said communities were worried.The government said there were "high safety standards in place" and BESS were a protection against "future energy shocks".
BESS hold excess energy generated by wind and solar farms and then release it into the grid when the power is needed most.Lithium-ion batteries - found in phones, e-bikes and electric vehicles - are used in large numbers.Mr Griffin warned the scale of BESS meant firefighters were having to learn new techniques."There can be complications with vapour clouds and fires will last a long time," he added."It is an emerging risk for us and we are alive to it."He wanted fire services to be given more power to enforce safety measures, as they were only allowed to give "direction and professional advice"."I'd like to see a power that is akin to a regulatory order, where we would have the power to enforce safety measures on those sites," Mr Griffin said.
Prof Paul Christensen, a lithium-ion battery expert at the University of Newcastle, said cells underwent "thermal runaway" when damaged.This is where the current flowing through the battery on charge causes its temperature to rise, potentially causing a fire."These reactions produce large volumes of gas explosive and toxic gas, but also heat," he said."Eventually what you get is the gas venting from the individual cells. This can ignite to flames or you can actually get an explosion."Prof Christensen stressed the batteries were often "perfectly safe" when operated within the set limits.
A BESS can be standalone or attached to a solar farm. In Suffolk, a number are already operating and there are more in the pipeline:Three BESS will accompany the agreed £600m Sunnica solar farm in west SuffolkIn March, plans were agreed for a 400MW BESS near Bramford in Ipswich In February, a 101-acre (41-hectare) solar farm and accompanying BESS was agreed for Halesworth in east SuffolkA government database tracking the progress of UK renewable electricity schemes over 150kW through the planning system lists 1,867 battery projects.According to the online tool, 211 are operational or under construction.
Dr Catherine Judkins is the chairwoman of the Say No to Sunnica community group.She said some residents were "absolutely petrified" by fires BESS could cause at the 2,500-acre (1,011-hectare) site."They burn for many hours, if not days and weeks," Dr Judkins said."While they're burning they omit highly toxic emissions over wide areas and have caused, in other cities across the world, mass evacuations."Plans for Sunnica were approved by the government last July and the proposal included measures to avoid, reduce or mitigate fire risk.West Suffolk MP Nick Timothy said "the threat of sabotage" at nearby RAF Mildenhall should also be taken into account.
Battery storage is regulated by the Health and Safety Executive, which checks safety measures put in place by operators and installers.A spokesperson for the Department for Energy Security and Net Zero added: "Every wind turbine we put up, every solar panel we install and every battery storage facility we construct helps protect families from future energy shocks."Battery fires at storage sites are rare in the UK. "We already have high safety standards in place that require manufacturers and industry to ensure batteries are safe throughout their lifespan."Sunnica was approached for comment.
Follow Suffolk news on BBC Sounds, Facebook, Instagram and X.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Amazon shoppers rush to buy ‘stylish powerhouse' £140 MagSafe portable charger – now just £27
Amazon shoppers rush to buy ‘stylish powerhouse' £140 MagSafe portable charger – now just £27

The Sun

timean hour ago

  • The Sun

Amazon shoppers rush to buy ‘stylish powerhouse' £140 MagSafe portable charger – now just £27

I'VE tested my fair share of portable chargers, and this one ticks all the right boxes. The Aobbow MagSafe Power Bank is on sale right now, down 81% from £139.99 to just £26.99, and it has everything you need. Aobbow MagSafe Power Bank, £139.99 £26.99 BUY FROM AMAZON Amazon's no stranger to solid tech deals, but this one feels like it's punching well above its price tag. For under thirty quid, you're getting a 10,000mAh portable charger that's slim, travel-friendly, and loaded with features. It supports wireless charging and comes with two built-in cables, one Type-C and one Lightning, as well as two additional ports. That's a rare combo, and a design you usually only see in premium models that cost two or three times as much. Now, let's be honest, £139.99 may have been stretching it a bit. But £26.99 is a real bargain for what you're getting here, and it's the kind of deal I wouldn't think twice about if you need a reliable power bank. I've tested plenty of chargers in search of the best power banks out there, and this one hits that sweet spot between practicality and price. It's compact, lightweight, and genuinely useful for everyday life, whether that's commuting, travelling, or just for a quick top-up on the go. And I'm not the only one who thinks so. The reviews on Amazon are overwhelmingly positive, with a near-perfect 4.9-star average and hundreds of buyers singing its praises. I haven't had this one in my hand yet, but in my opinion, it has everything I'd want in a portable charger. It's designed with iPhones in mind, supporting wireless charging from the 12 series all the way up to the latest iPhone 16 models. It even sticks to MagSafe-compatible cases, so it stays put while it charges. If you're not clear on the mechanics of wireless charging, our tech experts have a straightforward guide on how iPhone wireless charging works. But the Aobbow is far from limited to Apple gear, it supports wireless charging for Android phones, tablets, and other USB-C devices. The built-in display shows you exactly how much charge is left, which is a small touch that makes a big difference. And when you make full use of it, you can juice up to five devices at once, so it's great for family trips or group travel. People who've bought it seem genuinely impressed. One reviewer called it a 'stylish powerhouse,' adding, 'It gave my iPhone 15 about 50% juice in just 30 minutes. 'The 10,000mAh capacity easily delivers 1.5–2 full charges depending on your model.' Another praised its convenience, saying, 'It snaps right onto my phone and charges fast with the 20W. 'The built-in cables are a great bonus, and it's compact enough to carry daily. Great design, fast charging, and no hassle.' If you're after a reliable, well-equipped power bank that won't cost a fortune, this one's worth grabbing while it's around.

Lawyers warned to stop using ChatGPT to argue lawsuits after AI programs 'made up fictitious cases'
Lawyers warned to stop using ChatGPT to argue lawsuits after AI programs 'made up fictitious cases'

Daily Mail​

time5 hours ago

  • Daily Mail​

Lawyers warned to stop using ChatGPT to argue lawsuits after AI programs 'made up fictitious cases'

Lawyers in England and Wales have been warned they could face 'severe sanctions' including potential criminal prosecution if they present false material generated by AI in court. The ruling, by one of Britain's most senior judges, comes on the back of a string of cases in which which artificially intelligence software has produced fictitious legal cases and completely invented quotes. The first case saw AI fabricate 'inaccurate and fictitious' material in a lawsuit brought against two banks, The New York Times reported. Meanwhile, the second involved a lawyer for a man suing his local council who was unable to explain the origin of the nonexistent precedents in his legal argument. While large language models (LLMs) like OpenAI 's ChatGPT and Google 's Gemini are capable of producing long accurate-sounding texts, they are technically only focused on producing a 'statistically plausible' reply. The programs are also prone to what researchers call 'hallucinations' - outputs that are misleading or lack any factual basis. AI Agent and Assistance platform Vectera has monitored the accuracy of AI chatbots since 2023 and found that the top programs hallucinate between 0.7 per cent and 2.2 per cent of the time - with others dramatically higher. However, those figures become astronomically higher when the chatbots are prompted to produce longer texts from scratch, with market leader OpenAI recently acknowledging that its flagship ChatGPT system hallucinates between 51 per cent and 79 per cent of the time if asked open-ended questions. While large language models (LLMs) like OpenAI's ChatGPT and Google's Gemini are capable of producing long accurate-sounding texts, they are technically only focused on producing a 'statistically plausible' reply - which can lead to them 'hallucinating' false information Dame Victoria Sharp, president of the King's Bench Division of the High Court, and Justice Jeremy Johnson KC, authored the new ruling. In it they say: 'The referrals arise out of the actual or suspected use by lawyers of generative artificial intelligence tools to produce written legal arguments or witness statements which are not then checked, so that false information (typically a fake citation or quotation) is put before the court. 'The facts of these cases raise concerns about the competence and conduct of the individual lawyers who have been referred to this court. 'They raise broader areas of concern however as to the adequacy of the training, supervision and regulation of those who practice before the courts, and as to the practical steps taken by those with responsibilities in those areas to ensure that lawyers who conduct litigation understand and comply with their professional and ethical responsibilities and their duties to the court.' The pair argued that existing guidance around AI was 'insufficient to address the misuse of artificial intelligence'. Judge Sharp wrote: 'There are serious implications for the administration of justice and public confidence in the justice system if artificial intelligence is misused,' While acknowledging that AI remained a 'powerful technology' with legitimate use cases, she nevertheless reiterated that the technology brought 'risks as well as opportunities.' In the first case cited in the judgment, a British man sought millions in damages from two banks. The court discovered that 18 out of 45 citations included in the legal arguments featured past cases that simply did not exist. Even in instances in which the cases did exist, often the quotations were inaccurate or did not support the legal argument being presented. The second case, which dates to May 2023, involved a man who was turned down for emergency accommodation from the local authority and ultimately became homeless. His legal team cited five past cases, which the opposing lawyers discovered simply did not exist - tipped off by the fact by the US spellings and formulaic prose style. Rapid improvements in AI systems means its use is becoming a global issue in the field of law, as the judicial sector figures out how to incorporate artificial intelligence into what is frequently a very traditional, rules-bound work environment. Earlier this year a New York lawyer faced disciplinary proceedings after being caught using ChatGPT for research and citing a none-existent case in a medical malpractice lawsuit. Attorney Jae Lee was referred to the grievance panel of the 2nd U.S. Circuit Court of Appeals in February 2025 after she cited a fabricated case about a Queens doctor botching an abortion in an appeal to revive her client's lawsuit. The case did not exist and had been conjured up by OpenAI's ChatGPT and the case was dismissed. The court ordered Lee to submit a copy of the cited decision after it was not able to find the case. She responded that she was 'unable to furnish a copy of the decision.' Lee said she had included a case 'suggested' by ChatGPT but that there was 'no bad faith, willfulness, or prejudice towards the opposing party or the judicial system' in doing so. The conduct 'falls well below the basic obligations of counsel,' a three-judge panel for the Manhattan-based appeals court wrote. In June two New York lawyers were fined $5,000 after they relied on fake research created by ChatGPT for a submission in an injury claim against Avianca airline. Judge Kevin Castel said attorneys Steven Schwartz and Peter LoDuca acted in bad faith by using the AI bot's submissions - some of which contained 'gibberish' - even after judicial orders questioned their authenticity.

Statins almost halve the risk of death in patients critically ill with sepsis
Statins almost halve the risk of death in patients critically ill with sepsis

Daily Mail​

time6 hours ago

  • Daily Mail​

Statins almost halve the risk of death in patients critically ill with sepsis

Taking statins can improve the chances of surviving sepsis by 40 per cent, a trial has found. Sepsis can occur when the body's immune system overreacts to an infection and attacks its own organs. It is notoriously difficult to spot because the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins lower cholesterol to prevent heart attacks and strokes and are taken by around 5 million adults in the UK. But experts say they have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent (file image) In intensive care, 14.3 per cent of 6,000 sepsis patients given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. For those no longer in a critical condition, 11 per cent given statins died compared to 19 per cent who were not. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Researchers believe the drugs may help with sepsis by helping to combat bacteria directly, reducing the toll infection takes on the body. Earlier this year another study found the pills could also slash dementia risk – even in patients who don't have high cholesterol. The sepsis study, published in the journal Frontiers in Immunology, was based on data from thousands of patients at an Israeli hospital over a decade. Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'This study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Sepsis is known as the 'silent killer'. For every hour of delay in treatment, a patient's chance of dying increases 8 per cent. If caught early, it can be treated with antibiotics and fluids. Symptoms include slurred speech or confusion, shivering or muscle pain, passing no urine in a day, severe breathlessness and mottled or discoloured skin. Blood test to spot Alzheimer's early A Blood test for Alzheimer's can accurately detect the disease early, a study suggests. The test was 95 per cent accurate in identifying people with memory problems. It also scored 82 per cent for specificity, which means it was highly accurate in ruling out people without dementia. The study, published in the journal Alzheimer's and Dementia, found proteins amyloid beta 42/40 and p-tau217 in blood plasma can be examined to diagnose the condition. The study was carried out on more than 500 people in an outpatient memory clinic. The blood test has already been approved by the Food and Drug Administration regulator in the US.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store